JP2019535311A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019535311A5 JP2019535311A5 JP2019545700A JP2019545700A JP2019535311A5 JP 2019535311 A5 JP2019535311 A5 JP 2019535311A5 JP 2019545700 A JP2019545700 A JP 2019545700A JP 2019545700 A JP2019545700 A JP 2019545700A JP 2019535311 A5 JP2019535311 A5 JP 2019535311A5
- Authority
- JP
- Japan
- Prior art keywords
- virus
- item
- scpv
- viral genome
- items
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022140113A JP2022164900A (ja) | 2016-11-02 | 2022-09-02 | 合成キメラポックスウイルス |
| JP2024093677A JP2024107257A (ja) | 2016-11-02 | 2024-06-10 | 合成キメラポックスウイルス |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662416577P | 2016-11-02 | 2016-11-02 | |
| US62/416,577 | 2016-11-02 | ||
| US201662434794P | 2016-12-15 | 2016-12-15 | |
| US62/434,794 | 2016-12-15 | ||
| PCT/US2017/059782 WO2018085582A1 (en) | 2016-11-02 | 2017-11-02 | Synthetic chimeric poxviruses |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022140113A Division JP2022164900A (ja) | 2016-11-02 | 2022-09-02 | 合成キメラポックスウイルス |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019535311A JP2019535311A (ja) | 2019-12-12 |
| JP2019535311A5 true JP2019535311A5 (https=) | 2020-12-10 |
Family
ID=62075555
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019545700A Pending JP2019535311A (ja) | 2016-11-02 | 2017-11-02 | 合成キメラポックスウイルス |
| JP2022140113A Withdrawn JP2022164900A (ja) | 2016-11-02 | 2022-09-02 | 合成キメラポックスウイルス |
| JP2024093677A Pending JP2024107257A (ja) | 2016-11-02 | 2024-06-10 | 合成キメラポックスウイルス |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022140113A Withdrawn JP2022164900A (ja) | 2016-11-02 | 2022-09-02 | 合成キメラポックスウイルス |
| JP2024093677A Pending JP2024107257A (ja) | 2016-11-02 | 2024-06-10 | 合成キメラポックスウイルス |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US11345896B2 (https=) |
| EP (1) | EP3535389A4 (https=) |
| JP (3) | JP2019535311A (https=) |
| CN (1) | CN110431228B (https=) |
| AU (2) | AU2017353868C1 (https=) |
| BR (1) | BR112019008781A2 (https=) |
| CA (1) | CA3042694A1 (https=) |
| IL (2) | IL266399B2 (https=) |
| MX (1) | MX2019005102A (https=) |
| SG (1) | SG11201903893PA (https=) |
| TW (2) | TW202528334A (https=) |
| WO (1) | WO2018085582A1 (https=) |
| ZA (3) | ZA201902868B (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2019535311A (ja) | 2016-11-02 | 2019-12-12 | デイビッド エバンス， | 合成キメラポックスウイルス |
| US20180228921A1 (en) * | 2017-02-13 | 2018-08-16 | Excision Biotherapeutics, Inc. | Visualizing viral reservoirs and dissemination in vivo |
| EP3788142A4 (en) * | 2018-05-02 | 2022-04-27 | Tonix Pharma Holdings Limited | SYNTHETIC CHIMERIC VACCINE VIRUS |
| US20240024393A1 (en) * | 2019-01-25 | 2024-01-25 | Virocure, Inc. | Pharmaceutical composition for preventing or treating cancer, comprising squirrel fibroma virus and reovirus |
| US20230097513A1 (en) * | 2020-02-03 | 2023-03-30 | City Of Hope | Poxvirus-based vectors produced by natural or synthetic dna and uses thereof |
| KR20220165731A (ko) * | 2020-02-26 | 2022-12-15 | 토닉스 파마 리미티드 | Sars-cov-2 바이러스에 대한 재조합 폭스바이러스 기반 백신 |
| EP4153228A4 (en) | 2020-05-17 | 2024-07-10 | City of Hope | CORONAVIRUS VACCINES BASED ON SYNTHETIC MODIFIED ANKARA VACCINE (SMVA) VIRUS |
| JP2024505274A (ja) | 2021-02-02 | 2024-02-05 | ゲオバックス インコーポレイテッド | ワクチン接種中のｔ細胞プライミングの強化において使用されるウイルスコンストラクト |
| WO2023168286A1 (en) | 2022-03-01 | 2023-09-07 | Tonix Pharmaceuticals Holding Corp. | Recombinant poxvirus based vaccine against the omicron strain of sars-cov-2 virus and variants thereof |
| CN117264909B (zh) * | 2023-10-25 | 2024-11-26 | 深圳湾实验室 | 反式互补缺陷猴痘病毒及其应用 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2787577A (en) | 1953-12-01 | 1957-04-02 | Lilly Co Eli | Stable smallpox vaccine |
| US4754065A (en) | 1984-12-18 | 1988-06-28 | Cetus Corporation | Precursor to nucleic acid probe |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| US4800159A (en) | 1986-02-07 | 1989-01-24 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences |
| US6723325B1 (en) | 2001-04-23 | 2004-04-20 | Acambis, Inc. | Smallpox vaccine |
| US20040014034A1 (en) * | 2002-06-06 | 2004-01-22 | Evans David H | Method of producing a recombinant virus |
| WO2005028634A2 (en) | 2003-09-18 | 2005-03-31 | Emory University | Improved mva vaccines |
| JPWO2006022215A1 (ja) | 2004-08-23 | 2008-05-08 | 財団法人ヒューマンサイエンス振興財団 | ＳＡＲＳ−コロナウイルスタンパク質をコードするＤＮＡを保有する組換えワクチニアウイルスＤＩｓ株、およびその利用 |
| CN101020055B (zh) | 2006-02-16 | 2012-08-08 | 中国疾病预防控制中心性病艾滋病预防控制中心 | 基于复制型痘苗病毒载体的sars疫苗 |
| EP2097517B1 (en) | 2006-10-16 | 2014-06-04 | Genelux Corporation | Recombinant Lister strain vaccinia virus encoding an anti-VEGF single chain antibody |
| US8795667B2 (en) * | 2007-12-19 | 2014-08-05 | Macrogenics, Inc. | Compositions for the prevention and treatment of smallpox |
| FI20115914L (fi) | 2011-09-16 | 2013-03-17 | Oncos Therapeutics Ltd | Muunnettu onkolyyttinen virus |
| WO2014160475A1 (en) | 2013-03-13 | 2014-10-02 | Aboody Karen S | Tropic cell based virotherapy for the treatment of cancer |
| WO2014166084A1 (en) | 2013-04-10 | 2014-10-16 | Totbiopharm Shanghai R & D Center | Mutant vaccinia virus strains, uses thereof and method of producing the same |
| EP3045181B1 (en) | 2015-01-19 | 2018-11-14 | Ludwig-Maximilians-Universität München | A novel vaccine against the middle east respiratory syndrome coronavirus (MERS-CoV) |
| CN108135996B (zh) | 2015-08-11 | 2022-06-21 | 卡利迪生物治疗有限公司 | 用以癌症治疗的天花疫苗 |
| AU2017332367B2 (en) | 2016-09-21 | 2021-12-23 | Stephen H. Thorne | High mobility group box i mutant |
| JP2019535311A (ja) | 2016-11-02 | 2019-12-12 | デイビッド エバンス， | 合成キメラポックスウイルス |
| ES2702618B2 (es) | 2017-09-04 | 2019-10-31 | Inst De Salud Carlos Iii | Producto de combinación que comprende una célula madre mesenquimatosa modificada y una sustancia antigénica. |
| CN112261951A (zh) | 2018-05-02 | 2021-01-22 | 通尼克斯制药控股有限公司 | 包含合成嵌合痘苗病毒的干细胞及其使用方法 |
| EP3788142A4 (en) | 2018-05-02 | 2022-04-27 | Tonix Pharma Holdings Limited | SYNTHETIC CHIMERIC VACCINE VIRUS |
-
2017
- 2017-11-02 JP JP2019545700A patent/JP2019535311A/ja active Pending
- 2017-11-02 WO PCT/US2017/059782 patent/WO2018085582A1/en not_active Ceased
- 2017-11-02 MX MX2019005102A patent/MX2019005102A/es unknown
- 2017-11-02 IL IL266399A patent/IL266399B2/en unknown
- 2017-11-02 TW TW113144133A patent/TW202528334A/zh unknown
- 2017-11-02 SG SG11201903893PA patent/SG11201903893PA/en unknown
- 2017-11-02 CN CN201780078546.0A patent/CN110431228B/zh active Active
- 2017-11-02 IL IL319942A patent/IL319942A/en unknown
- 2017-11-02 BR BR112019008781-8A patent/BR112019008781A2/pt active IP Right Grant
- 2017-11-02 AU AU2017353868A patent/AU2017353868C1/en active Active
- 2017-11-02 TW TW106137976A patent/TWI887191B/zh active
- 2017-11-02 EP EP17868045.0A patent/EP3535389A4/en active Pending
- 2017-11-02 US US15/802,189 patent/US11345896B2/en active Active
- 2017-11-02 CA CA3042694A patent/CA3042694A1/en active Pending
-
2019
- 2019-05-07 ZA ZA2019/02868A patent/ZA201902868B/en unknown
-
2022
- 2022-05-06 ZA ZA2022/04981A patent/ZA202204981B/en unknown
- 2022-05-27 US US17/827,320 patent/US12365879B2/en active Active
- 2022-09-02 JP JP2022140113A patent/JP2022164900A/ja not_active Withdrawn
-
2024
- 2024-02-15 AU AU2024200997A patent/AU2024200997A1/en not_active Abandoned
- 2024-05-02 ZA ZA2024/03393A patent/ZA202403393B/en unknown
- 2024-06-10 JP JP2024093677A patent/JP2024107257A/ja active Pending
-
2025
- 2025-06-25 US US19/249,853 patent/US20260022350A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019535311A5 (https=) | ||
| JP2021522784A5 (https=) | ||
| CA2786333C (en) | Vaccinia virus mutants containing the major genomic deletions of mva | |
| Delhon et al. | Genomes of the parapoxviruses ORF virus and bovine papular stomatitis virus | |
| JP7050044B2 (ja) | ポックスウイルスベクターを用いて増強された免疫応答を誘導するための組成物及び方法ベクター | |
| Morikawa et al. | An attenuated LC16m8 smallpox vaccine: analysis of full-genome sequence and induction of immune protection | |
| JP2023515582A5 (https=) | ||
| JP2014207903A5 (https=) | ||
| JP2010259446A5 (https=) | ||
| Meisinger-Henschel et al. | Introduction of the six major genomic deletions of modified vaccinia virus Ankara (MVA) into the parental vaccinia virus is not sufficient to reproduce an MVA-like phenotype in cell culture and in mice | |
| RU2019112725A (ru) | Композиции и способы для повышения стабильности трансгенов в поксвирусах | |
| CA3042694A1 (en) | Synthetic chimeric poxviruses | |
| Zhang et al. | Genomic sequence and virulence of clonal isolates of vaccinia virus Tiantan, the Chinese smallpox vaccine strain | |
| JP2024535145A (ja) | 改変ワクシニアウイルスアンカラ（ｍｖａ）による細胞傷害性導入遺伝子発現を下方調節するためのマイクロｒｎａの利用 | |
| Zhu et al. | The attenuation of vaccinia Tian Tan strain by the removal of the viral M1L-K2L genes | |
| CA2372709C (en) | Vector for integration of heterologous sequences into poxviral genomes | |
| CN1723285A (zh) | 重组的mva及其产生方法 | |
| JP2021522789A5 (https=) | ||
| Wang et al. | Characterization of an attenuated TE3L-deficient vaccinia virus Tian Tan strain | |
| JP7034818B2 (ja) | 増殖性ヘルパーワクシニアウイルスを使用するポックスウイルスの製造方法 | |
| NZ752893B2 (en) | Synthetic chimeric poxviruses | |
| Danila | The analysis of the complete genome of Ectromelia virus strain Moscow, the causative agent of mousepox. | |
| WO2016062226A1 (zh) | 复制型痘苗病毒载体艾滋病疫苗 | |
| CA2929600C (en) | Compositions and methods vectors for inducing an enhanced immune response using poxvirus vectors | |
| Skinner et al. | Recombinant Avipoxviruses |